Tag:
Satori Pharmaceuticals
Latest Headlines
Latest Headlines
Can an herbal medicine provide the key to defeating Alzheimer's?
Could a molecule in black cohos prove to be a safe and effective treatment for Alzheimer's disease?
Satori snags $15M to fuel a trial on Alzheimer's drug
Satori Pharmaceuticals is banking $15 million in debt financing intended to back a theory that their beta amyloid 42 peptide pill could eventually treat Alzheimer's.
Biotechs lay siege to misfolded proteins
A slate of biotech companies are devoting time and a considerable amount of money to study the ways in which misfolded proteins spur disease--and the therapies that can cure the ailments. The Boston
Satori gains $22M to push Alzheimer's work
Satori Pharmaceuticals has raised $22 million to advance new drugs designed to stop Alzheimer's at an early stage. InterWest Partners, Prospect Venture Partners, New Enterprise Associates, PureTech
